Your browser doesn't support javascript.
loading
Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment.
Sottilotta, Gianluca; Mangano, Carmelo; Basile, Rosa; Falcone, Carmela; Luise, Francesca; Megalizzi, Demetrio; Nicolò, Giovanna Maria; Oriana, Vincenzo; Piromalli, Angela.
Afiliação
  • Sottilotta G; Hemophilia Centre, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
  • Mangano C; Infectious Disease Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
  • Basile R; Infectious Disease Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
  • Falcone C; Radiology Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
  • Luise F; Analysis Laboratory, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
  • Megalizzi D; Hemophilia Centre, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
  • Nicolò GM; Clinical Pathology, University of Catania, Catania, Italy.
  • Oriana V; Hemophilia Centre, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
  • Piromalli A; Analysis Laboratory, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
SAGE Open Med Case Rep ; 9: 2050313X211016991, 2021.
Article em En | MEDLINE | ID: mdl-34104443
ABSTRACT
Patients with COVID-19 are at high risk of thromboembolic events; for this reason, the use of heparin is largely recommended but, in addition to thrombotic complications, bleeding is a significant cause of morbidity in patients with COVID-19. Idiopathic iliopsoas hematoma is a very rarely described hemorrhagic complication in patients with COVID-19. We report here two cases of iliopsoas hematoma in male patients with COVID-19 and being treated with heparin.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article